IRVINE, CA (PRWEB) December 20, 2013

Proove Biosciences, the leader in providing personalized genetic pain medicine services, participated and presented clinical data and research at the Eastern Pain Associations Annual Meeting on December 7, 2013. The meeting covered current topics in pain medicine and opioid treatment, and took place at the New York Marriott Downtown, in Manhattan.

The EPA offers local and regional scientific meetings to foster an exchange of clinical and scientific information among multidisciplinary health professionals and researchers interested in the field of pain. The Annual EPA Scientific Meeting offered symposia and lectures given by nationally recognized speakers, posters and exhibits designed to appeal to a wide spectrum of specialists and interests.

The EPAs Annual Meeting concluded a successful and busy year for Proove presenting research throughout the country. Most recently, Proove presented data and findings at the ASRAs Pain Medicine Meeting, The National Workers Compensation Conference and Expo, and the Common Sense Pain Management Conference.

Our research and clinical team, along with our aggressive business development efforts have allowed Proove to experience outstanding growth throughout the year, stated Proove Biosciences President and Founder,Brian Meshkin. We are the only company providing proprietary testing services in personalized pain medicine. We are happy to have been a part of the EPAs regional meeting, and exhibiting our work with physicians, psychologists, nurses, and scientists dedicated to pain research.

About Proove Biosciences Proove Biosciences is the leading Personalized Pain Medicine laboratory that provides proprietary genetic testing services to help physicians improve outcomes for patients and contain costs for insurers. With offices in Southern California and the Baltimore-Washington metropolitan area, the Company is the research leader investigating and publishing data on the genetics of pain medicine with clinical research sites across the United States. Physicians use Proove Biosciences testing to improve pain medicine selection, dosing, and evaluation of medications they prescribe. From a simple cheek swab collected in the office, Proove performs proprietary genetic tests in its CLIA-certified laboratory to identify patients at risk for misuse of prescription pain medications and evaluate their metabolism of medications. For more information, please visit http://www.proovebio.com or call toll free 855-PROOVE-BIO (855-776-6832).

More:
Proove Biosciences Successfully Presents Data and Exhibits at the Eastern Pain Association’s Annual Meeting in New ...

Comments are closed.